Unternehmensprofil · Healthcare

Cardinal Health Inc

CAH · USA
Börse
USA
Land / Region
USA
Börsengang
31. Dezember 1987
Mitarbeiter
53.084
Aktueller Kurs
$221.77
Live · 18. Juni 2026
Baillie-Wachstumsscore
41/100
Eher schwach
Innerer Wert · Drei-Stufen-Bereich Aktueller Kurs $221.77 Live · Zwischen dem fairen und dem optimistischen Bereich

Zusammengesetzter Bewertungsbereich · konservativ $130–$160 / fair $175–$215 / optimistisch $240–$300. Bei $221.77, Zwischen dem fairen und dem optimistischen Bereich.

Bei Veröffentlichung $200.68 (24. Mai 2026)

Noch keine Analysen zu dieser Aktie in Ihrer Sprache.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Marktkapitalisierung53 Mrd. $
Umsatz (TTM)250,74 Mrd. $
EBITDA3,99 Mrd. $
Nettomarge0,62 %
ROE0 %
KGV (TTM)34,6
Erwartetes KGV19,05
PEG1,4
EPS6,54 $
Dividendenrendite0,9 %
52-Wochen-Spanne136,63 $ – 233,04 $
Analysten-Kursziel245,27 $
Analystenbewertung4.1 / 5

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

Geschichte

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Branchenposition

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.